Obesity in women decreases risk of glaucoma

Article

Females with a higher body mass index (BMI) are less likely to develop open-angle glaucoma (OAG).

Females with a higher body mass index (BMI) are less likely to develop open-angle glaucoma (OAG), according to a recent study published in the Archives of Ophthalmology.

Dr Wishal D. Ramdas et al., Department of Epidemiology, Erasmus Medical Center, Rotterdam, The Netherlands, conducted the prospective population-based cohort Rotterdam Study on 3939 participants without OAG. The initial purpose of the investigation was to determine whether factors such as socioeconomic status, smoking, alcohol consumption and obesity influence the development of OAG.

The same ophthalmologic examinations were performed on all participants, including intraocular pressure measurements, optic nerve head assessment and perimetry.

Of 3939 participants, 108 contracted OAG during 9.7 years' mean follow-up. The findings show that for every unit increase in BMI in women, the risk of developing OAG increases by 7%. No significant results were found for socioeconomic status, smoking and alcohol consumption. There were no associations between obese males and glaucoma.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
Elizabeth Cohen, MD, discusses the Zoster Eye Disease study at the 2024 AAO meeting
Victoria L Tseng, MD, PhD, professor of ophthalmology and glaucoma specialist, UCLA
© 2025 MJH Life Sciences

All rights reserved.